Pfizer Forecasts $54 Billion in 2022 Sales From Its Covid-19 Vaccine, Treatment
As Pfizer Inc. PFE -2.84% forecasts strong sales this year for its Covid-19 vaccine and treatment, the drugmaker is on...
Albert Bourla
Pfizer Submits Covid-19 Pill for FDA Authorization
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
U.S. to Invest More Than $3 Billion in Covid-19 Antiviral Development
WASHINGTON—The Biden administration will invest more than $3 billion on developing and manufacturing antiviral pills to treat coronavirus, the Department...
AstraZeneca Releases Covid-19 Vaccine Data Showing 76% Efficacy
AstraZeneca PLC released more pivotal-trial data for its Covid-19 vaccine, saying the shot was 76% effective at preventing Covid-19 with...
